NeuroStar® in the News

To learn more about how physicians throughout the country are successfully treating depression with NeuroStar TMS Therapy®, see the recent media coverage and press releases below.


Recent press coverage about NeuroStar TMS Therapy
2016
Sep
01
HPR – What Patients Should Consider When Choosing Transcranial Magnetic Stimulation Therapy
Sep
01
HPR – Clinical Results for Major Depressive Disorder and Generalized Anxiety Disorder
Sep
01
HPR – Transcranial Magnetic Stimulation Therapy for Depression
Jun
01
PM360 – NeuroStar Advocate Martha Rhodes Among Winners Of Second Annual Elite Awards

See archived articles about NeuroStar TMS Therapy


Recent press releases about NeuroStar TMS Therapy
2016
May
17
NeuroStar TMS Therapy®, a Non-Drug Treatment, Shows Promise as Monotherapy in Treating Women with Postpartum Depression
Mar
24
Depression Patients Who Are Successfully Treated With NeuroStar TMS Therapy May Not Need Antidepressant Medications
2015
Nov
02
Neuronetics Announces Launch of First Ever Randomized, Controlled Clinical Trial to Evaluate Non-Drug NeuroStar TMS Therapy® in Adolescent Patients with Major Depressive Disorder
Sep
01
Neuronetics Named PM360 Trailblazer Finalist for Medical Device Company of the Year
Apr
27
Neuronetics Closes $34 Million in Series F Financing with GE Ventures and Current Investors
Feb
23
Australians to Gain Access to Breakthrough Treatment for Depression

See archived press releases about NeuroStar TMS Therapy